Call for Abstracts Submission

SABM 2026 Annual Meeting

Scientific Abstract Submission Guidelines

How to Submit an Abstract

• Delegates who would like to present their work at the SABM 2026 Annual Meeting, either orally or as an electronic poster, are invited to submit an abstract for consideration by the Scientific Committee.
• SABM Members and Non-Members are invited to submit abstracts.
• There are no fees to submit an abstract.
• Abstracts can only be submitted online via the abstract submission website during the submission period from February 2 – May 11, 2026.
• The submitter will be required to create a new user account to submit an abstract. Once logged in, you will be able to submit your abstract

Topics

• SABM Seeks scientific abstracts that address a broad range of topics relevant to Patient Blood Management (PBM). This can include the reporting of basic, translational, and clinical research; quality improvement projects and safety initiatives; regulatory and advocacy work; PBM implementation projects; and case series/reports, amongst others.

Format

• Abstracts should be structured with  Background, Methods, Results, and Conclusion. Case reports and case series may substitute Case Description for Methods and Results, as appropriate.

General Guidelines

• The abstract should generally address scientific questions, detail clinical observations, or contain primary scientific data.
• Abstracts MUST be submitted English.  Abstracts submitted in any language other than English will be automatically rejected. All authors are encouraged to have their abstracts checked for grammar and spelling.
• Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as accepted abstracts will be published exactly as submitted. Linguistic accuracy is your responsibility. No proofreading will be done.
• All research and studies in submitted abstracts that involve human subjects or experimental animals must comply with the Declaration of Helsinki. They must have been approved by the appropriate agencies and have been in accordance with applicable ethical standards.
• You may make edits and revisions through May 11, 2026. No revisions can be made after the abstract deadline of May 11, 2026, and no late submissions will be accepted. To ensure the integrity of the review process, revisions to abstracts and submissions will not be accepted after the abstract submission deadline.
• Presenting Authors should be prepared to present their work at the date and time listed in their acceptance notification or should provide SABM with an alternate presenter from the list of their co-authors by August 1, 2026.
• Additional Submission Requirements:
  • The combined length of the abstract body may not exceed 400 words.  Authors have the option to submit 1 table and/or 1 figure with their submission.  This does not count toward the 400 word count limit.
  • Titles should be indicative of the content of the abstract and be brief.
  • The author(s) should include appropriate statistics when presenting data to permit interpretation.
  • Author(s) are encouraged to save an electronic or printed copy of their abstract for their records before submitting.
  • The first instance of an acronym must be spelled out with the acronym in parentheses, e.g., Patient Blood Management (PBM).
  • You will be required to submit Headshot with your submission.

Work previously submitted elsewhere

• Abstracts describing work that has been previously presented at another scientific meeting are not eligible for submission and will not be accepted. Abstracts must not have been published as a full manuscript in a peer-reviewed journal at the time of submission. Manuscripts that are accepted for publication or published after abstract submission but before the start of the SABM Annual Meeting remain eligible. Submission of multiple abstracts derived from the same study is discouraged and may be reviewed for overlap or redundancy.

Responsibilities of the Presenting Author

• The presenting author serves as the primary contact for all correspondence about the abstract. No other co-authors on the abstract will receive correspondence from SABM. The presenting author is responsible for forwarding any SABM communications about the abstract/presentation to the respective co-authors.
• The abstract's presenting author must register for the Annual Meeting. The abstract(s) will be withdrawn if registration is not completed by August 15, 2026.
• The submission of an abstract constitutes a formal commitment by the submitting (presenting) author to present the abstract in person (if accepted) in the session and at the time assigned by SABM.
• Presenting authors will be responsible for registering and paying the appropriate fees to attend the Annual Meeting, securing travel documents/authorization, and covering all associated costs (travel, hotel, meals, etc.).

Abstract Selection and Notification

• Submitted abstracts will be peer reviewed for acceptance based on their overall scientific quality. Authors will be notified via email by May 31, 2026 of their abstracts' acceptance or rejection. If accepted, authors will be expected to present their scientific abstracts at the SABM 2026 Annual Meeting. Three top abstracts will be chosen for oral presentations at the SABM 2026 Annual Meeting. All other accepted abstracts will be presented as posters.

Publishing Accepted Abstracts

• Accepted abstracts may be published in Anesthesia and Analgesia, at the discretion of SABM.